Related Experiment Video
Updated: May 15, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Antimicrobial susceptibilities of Clostridium difficile isolated in Japan
Hiroyuki Kunishima1, Junichi Chiba, Michiko Saito
1Department of Infection Control and Laboratory Diagnostics, Internal Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Japan. h2kuni@med.tohoku.ac.jp
Abstract:
Clostridium difficile is a common causative organism of antimicrobial-associated diarrhea and is often responsible for nosocomial infection. C. difficile infection has traditionally been treated with metronidazole (MNZ) or vancomycin (VCM); however, MNZ-resistant strains have reported in some countries. In this study the broth microdilution method was used to determine the minimum inhibitory concentrations (MICs) of 15 drugs against 157 clinical isolates of C. difficile in Japan. All C. difficile isolates tested were susceptible to MNZ; MIC50 was 0.25 μg/ml, MIC90 was 0.5 μg/ml, and MIC range was 0.06-1 μg/ml. C. difficile isolates were also susceptible to VCM; MIC50 was 0.5 μg/ml, MIC90 was 1 μg/ml, and MIC range was 0.12-2 μg/ml. Susceptibility to teicoplanin was also similar: MIC50 was 0.12 μg/ml, MIC90 was 0.12 μg/ml, and MIC range was 0.03-0.25 μg/ml. The susceptibility of C. difficile isolates must be monitored continuously because a strain with reduced susceptibility to MNZ or VCM might emerge in the future.
Insights
All Japanese Clostridium difficile isolates were susceptible to metronidazole (MNZ) and vancomycin (VCM). Continuous monitoring is crucial as resistant strains may emerge, impacting antimicrobial-associated diarrhea treatment.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Clostridium difficile causes antimicrobial-associated diarrhea and nosocomial infections.
- Metronidazole (MNZ) and vancomycin (VCM) are standard treatments.
- Emergence of MNZ-resistant strains necessitates ongoing surveillance.
Purpose of the Study:
- To determine the susceptibility of clinical Clostridium difficile isolates in Japan to various antimicrobial agents.
- To assess the minimum inhibitory concentrations (MICs) of 15 drugs against C. difficile.
Main Methods:
- Broth microdilution method was employed.
- 157 clinical isolates of C. difficile from Japan were tested.
- MICs for 15 different drugs were determined.
Main Results:
- All 157 C. difficile isolates were susceptible to metronidazole (MNZ).
- All isolates were also susceptible to vancomycin (VCM) and teicoplanin.
- MIC ranges and MIC50/MIC90 values for MNZ, VCM, and teicoplanin were established.
Conclusions:
- Current Japanese C. difficile isolates remain susceptible to MNZ and VCM.
- Continuous monitoring of antimicrobial susceptibility is essential to detect potential resistance.
- Proactive surveillance will guide future treatment strategies for C. difficile infections.
Related Concept Videos
Antimicrobial Effectiveness
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
